Skip to main content

Table 7 Treatment and outcome - Entities occurring at all ages (B), continues table 6

From: Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany

Patient No. Mechanical ventilation Surfactant treatment, response O2 supply at rest Immuno-suppressive treatment Response to treatment Long term out-come**
22 No n.k.   n.k.   n.k.
23 No n.k.   Systemic steroids good alive
24 No no   Systemic steroids good n.k.
25 No n.k.   Systemic steroids good alive
26 No n.k. no Systemic steroids good alive
27 No n.k. 0.5-1 l/min Systemic steroids good alive
28 No no   Systemic steroids good alive
29 No no 1-2 l/min Systemic steroids good alive
30 No no 2 l/min No steroids, allergen removal good alive
31 No n.k. no No steroids, allergen removal good alive
32 No no   Systemic steroids good alive
33 No no   Systemic steroids good alive
34 No n.k.   Systemic steroids good alive
35 No n.k.   Systemic steroids good alive
36 No no   Systemic steroids good n.k.
37 No n.k. 0,3 l/min n.k.   n.k.
38 n.k. n.k. no n.k.   n.k.
  1. * Initial symptoms within the neonatal period; ** Follow up information was obtained one year after inclusion of the subject into the survey
  2. n.k., not known;